Improving minimal residual disease detection in precursor B-ALL based on immunoglobulin-κ and heavy-chain gene rearrangements
Open Access
- 22 May 2008
- journal article
- letter
- Published by Springer Nature in Leukemia
- Vol. 22 (12) , 2265-2267
- https://doi.org/10.1038/leu.2008.121
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemiaLeukemia, 2008
- Relapse in children with acute lymphoblastic leukemia involving selection of a preexisting drug-resistant subcloneBlood, 2007
- Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR dataLeukemia, 2007
- Development of immunoglobulin variable heavy chain gene consensus probes with conjugated 3′ minor groove binder groups for monitoring minimal residual disease in childhood acute lymphoblastic leukaemiaJournal of Clinical Pathology, 2003
- T cell receptor gamma gene rearrangements as targets for detection of minimal residual disease in acute lymphoblastic leukemia by real-time quantitative PCR analysisLeukemia, 2002
- Immunoglobulin kappa deleting element rearrangements in precursor-B acute lymphoblastic leukemia are stable targets for detection of minimal residual disease by real-time quantitative PCRLeukemia, 2002
- Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemiaLeukemia, 2000
- Simultaneous detection and quantification of minimal residual disease in childhood acute lymphoblastic leukaemia using real‐time polymerase chain reactionBritish Journal of Haematology, 2000